Loading company details...
Beta
Latest Form 4 (Mar 3, 2026): Frank Bedu-Addo (President/CEO): Grant/Award of 548,782 shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Mar 3, 2026 | Frank Bedu-Addo, President/CEO | Grant/Award | 548,782 | n/a |
| Mar 3, 2026 | Gregory Conn, Chief Scientific Officer | Grant/Award | 150,000 | n/a |
| Mar 3, 2026 | Kirk Shepard V., Chief Medical Officer | Grant/Award | 300,000 | n/a |
| Mar 3, 2026 | Lars Boesgaard, Chief Financial Officer | Grant/Award | 300,000 | n/a |
| Mar 3, 2026 | Spencer D. Brown, Senior VP, General Counsel | Grant/Award | 300,000 | n/a |
| Mar 3, 2026 | Stephan Toutain, Chief Operating Officer | Grant/Award | 300,000 | n/a |
| Mar 3, 2026 | Gregory Gene Freitag | Grant/Award | 54,876 | n/a |
| Mar 3, 2026 | Ilian Iliev | Grant/Award | 54,876 | n/a |
| Mar 3, 2026 | Kamil Ali-Jackson | Grant/Award | 54,876 | n/a |
| Mar 3, 2026 | Otis W. Brawley | Grant/Award | 54,876 | n/a |